Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Net Change in Cash
Combined operating, investing, financing, and currency effects on the cash balance during the period.
Net Change in Cash history
Currency unavailable · from the cash flow
No Net Change in Cash data reported for this period type.
Net Change in Cash vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $251.53M USD | +234.5% | +146.5% | 89.2% | |
| LTM Mar 2026 | $172.33M USD | +307.6% | — | — | |
| LTM Mar 2026 | $149.83M USD | +233.4% | — | 64.5% | |
ORKAOruka Therapeutics, Inc. | LTM Sep 2026 | $100.27M USD | +131.4% | +10.3% | — |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | $88.34M USD | +2748.7% | +2.1% | 1194.1% |
| LTM Sep 2026 | $17.83M USD | +366.8% | — | 19.7% | |
| LTM Mar 2026 | $1.7M USD | -69.1% | — | 20.3% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | — | — | — | — | — |
| Peer median (excluding ODTX) | — | +234.5% | +10.3% | 64.5% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.